Market Cap : 298.57 M | Enterprise Value : | PE Ratio : | PB Ratio : 0.52 |
---|
NYSE:HCHC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:HCHC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. HC2 Holdings's research and development for the three months ended in Dec. 2020 was $0 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2020 was $0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
This is the expense the company spent on research and development.
Research & Development for the trailing twelve months (TTM) ended in Dec. 2020 was 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) + 0 (Dec. 2020 ) = $0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
No Headline